0001140361-16-069073.txt : 20160608 0001140361-16-069073.hdr.sgml : 20160608 20160608143633 ACCESSION NUMBER: 0001140361-16-069073 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160608 DATE AS OF CHANGE: 20160608 EFFECTIVENESS DATE: 20160608 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001600987 IRS NUMBER: 464137807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-264575 FILM NUMBER: 161703344 BUSINESS ADDRESS: STREET 1: 1737 GRAND AVE. CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: (619) 987-7768 MAIL ADDRESS: STREET 1: 1737 GRAND AVE. CITY: DEL MAR STATE: CA ZIP: 92014 FORMER COMPANY: FORMER CONFORMED NAME: TOKALAS, INC. DATE OF NAME CHANGE: 20140225 D 1 primary_doc.xml X0707 D LIVE 0001600987 Oncternal Therapeutics, Inc. 1737 Grand Ave. Del Mar CA CALIFORNIA 92014 (619) 987-7768 DELAWARE Tokalas, Inc. TOKALAS, INC. Corporation true 2013 James B. Breitmeyer, M.D., Ph.D. Oncternal Therapeutics, Inc. 1737 Grand Ave. Del Mar CA CALIFORNIA 92014 Director Executive Officer President and Chief Executive Officer David F. Hale c/o Oncternal Therapeutics, Inc. 1737 Grand Ave. Del Mar CA CALIFORNIA 92014 Director Cam Garner c/o Oncternal Therapeutics, Inc. 1737 Grand Ave. Del Mar CA CALIFORNIA 92014 Director David Johnson c/o Oncternal Therapeutics, Inc. 1737 Grand Avenue Del Mar CA CALIFORNIA 92014 Director Scott Glenn c/o Oncternal Therapeutics, Inc. 1737 Grand Avenue Del Mar CA CALIFORNIA 92014 Director Karen Lundgren c/o Oncternal Therapeutics, Inc. 1737 Grand Ave. Del Mar CA CALIFORNIA 92014 Executive Officer Vice President and Chief Scientific Officer Dana McGowan c/o Oncternal Therapeutics, Inc. 1737 Grand Ave. Del Mar CA CALIFORNIA 92014 Executive Officer Treasurer and Secretary Lauren G. Otsuki c/o Oncternal Therapeutics, Inc. 1737 Grand Ave. Del Mar CA CALIFORNIA 92014 Executive Officer Chief Business Officer James Freddo c/o Oncternal Therapeutics, Inc. 1737 Grand Ave. Del Mar CA CALIFORNIA 92014 Executive Officer Chief Medical Officer Biotechnology Decline to Disclose 06b false 2016-05-27 false true true 0 13135714 13135714 0 false 26 0 0 0 false Oncternal Therapeutics, Inc. /s/ James B. Breitmeyer James B. Breitmeyer, M.D., Ph.D. President and Chief Executive Officer 2016-06-08